- Report
- September 2023
- 23 Pages
Israel
From €825EUR$919USD£732GBP
- Report
- September 2021
- 26 Pages
Ukraine
From €825EUR$919USD£732GBP
- Report
- April 2023
- 438 Pages
Global
From €5594EUR$5,820USD£4,797GBP
- Report
- April 2024
- 140 Pages
From €4805EUR$4,999USD£4,120GBP
- Report
- April 2023
- 147 Pages
Global
From €5766EUR$5,999USD£4,945GBP
The Common Cold market is a subset of the Cough and Cold Drugs market, which includes products used to treat symptoms of the common cold, such as sore throat, nasal congestion, and cough. These products are typically available over-the-counter and include decongestants, antihistamines, and cough suppressants. Many of these products are formulated with multiple active ingredients to provide relief from multiple symptoms.
The Common Cold market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, and Sanofi. Other companies, such as Procter & Gamble, Reckitt Benckiser, and Bayer, also offer products in this market. Show Less Read more